[Human mycobacterial infections: impact of host genetic factors]
- PMID: 12014265
[Human mycobacterial infections: impact of host genetic factors]
Abstract
Humans are exposed worldwide to a variety of environmental mycobacteria (EM) and most children are inoculated with live Bacille Calmette-Guérin (BCG) vaccine. Although rarely pathogenic, poorly virulent mycobacteria, including BCG and most EM, may cause a variety of clinical diseases. M. tuberculosis and M. leprae are more virulent, causing tuberculosis, and leprosy, respectively. Remarkably, only a minority of individuals develop clinical disease, even if infected with virulent mycobacteria. There is now accumulating evidence that the large interindividual variability of clinical outcome results in part from variability in the human genes that control host defense. We review here in current knowledge about genetic predisposition to common (leprosy and tuberculosis) and rare (BCG and EM infections) mycobacterial infections.
Similar articles
-
Genetic dissection of immunity to mycobacteria: the human model.Annu Rev Immunol. 2002;20:581-620. doi: 10.1146/annurev.immunol.20.081501.125851. Epub 2001 Oct 4. Annu Rev Immunol. 2002. PMID: 11861613 Review.
-
Control of human host immunity to mycobacteria.Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):53-64. doi: 10.1016/j.tube.2004.09.011. Epub 2004 Dec 31. Tuberculosis (Edinb). 2005. PMID: 15687028 Review.
-
Mendelian susceptibility to mycobacterial disease.Clin Genet. 2011 Jan;79(1):17-22. doi: 10.1111/j.1399-0004.2010.01510.x. Clin Genet. 2011. PMID: 20718793 Review.
-
Susceptibility to mycobacterial infections: the importance of host genetics.Genes Immun. 2003 Jan;4(1):4-11. doi: 10.1038/sj.gene.6363915. Genes Immun. 2003. PMID: 12595896 Review.
-
[Frontier of mycobacterium research--host vs. mycobacterium].Kekkaku. 2005 Sep;80(9):613-29. Kekkaku. 2005. PMID: 16245793 Japanese.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical